Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

BUY
$0.43 - $0.81 $9,569 - $18,025
22,254 New
22,254 $10,000
Q2 2022

Aug 09, 2022

BUY
$0.85 - $1.29 $16,757 - $25,432
19,715 New
19,715 $17,000
Q4 2021

Feb 17, 2022

SELL
$1.07 - $2.01 $28,997 - $54,470
-27,100 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.96 - $4.72 $53,116 - $127,912
27,100 New
27,100 $54,000

About Acasti Pharma Inc.


  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.